Project Grant HT94252510967
Award Date 11/1/25
Completion Date 10/31/27
Dollars Obligated $235K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Los Angeles, CA 90024, USA
Similar Awards
- The University of California, Los Angeles (UCLA) has been awarded a $626,081 Project Grant under the Military Medical Research and Development (CFDA 12.420) federal grant program, administered by the Defense Health Agency. The grant, titled "Combinatorial Phenotype-Targeted Therapy to Overcome Mechanisms Driving Prostate Cancer Treatment Resistance," will support advanced biomedical research to transform healthcare for military service members and the broader public. The research...
- This $188,403 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) is funding the University of California, Los Angeles (UCLA) to develop new cell-mediated immunotherapeutic strategies for small-cell lung cancer. The award period runs from January 1, 2025 to December 31, 2025. Through this funding, UCLA will conduct advanced biomedical research to transform healthcare for military service members, veterans, and the...
- The Defense Health Agency awarded a $468,000 Project Grant to the University of California, Los Angeles under the Military Medical Research and Development federal grant program (CFDA 12.420) to support research developing new therapeutic strategies to target TROP2 in aggressive prostate cancer. The two-year award beginning March 15, 2023 will fund research efforts to investigate medical solutions for prostate cancer on the battlefield and transform health care for service members and the public...
- This $472,500 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) is supporting research at the University of California, Los Angeles (UCLA) to investigate "Targeting TROP2-mediated ferroptosis as a new therapy for advanced prostate cancer." The project will be conducted over a 24-month period from May 1, 2025 to April 30, 2027. As a prominent federal research partner, UCLA will leverage its extensive research...
- The University of California, Los Angeles (UCLA), under its Office of Research Administration, received a $157,473 Project Grant award from the Defense Health Agency (DHA) on May 1, 2024 to conduct research for the "TESTING UCHL1 AS A NEW MINIMALLY INVASIVE BIOMARKER AND THERAPEUTIC TARGET FOR NEUROENDOCRINE PROSTATE CANCER" project. This award is funded through the DHA's Military Medical Research and Development program (CFDA 12.420), which supports a range of biomedical research...
- This federal Project Grant award, valued at $2,520,000.00, was issued by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The award supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The primary awardee, the University of California, Los Angeles (UCLA), will leverage its extensive facilities, diverse faculty expertise, and robust administrative capabilities...
- The Defense Health Agency has awarded a $1,626,500.00 Project Grant to the University of California, Los Angeles (UCLA) under the Military Medical Research and Development program (CFDA 12.420). This grant, awarded on September 15, 2025, supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The grant funds a range of research initiatives across medical domains such as cancer, neuroscience, infectious diseases, and...
- The University of California, Los Angeles (UCLA), through its Office of Research Administration, has been awarded a $2,351,564.00 Project Grant from the Defense Health Agency under the CFDA Program 12.420 - Military Medical Research and Development. This four-year grant, with a period of performance from August 15, 2023 to August 14, 2027, will support research targeting the EGFR signaling network in glioblastoma. As the prime grantee, UCLA will leverage its research facilities, faculty...
- This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $630,000.00 to the University of California, Los Angeles (UCLA) for intravesical nectin4 chimeric antigen receptor T cell therapy research for non-muscle invasive bladder cancer. The award period runs from September 1, 2024 to August 31, 2026. As the prime awardee, UCLA will leverage its facilities, faculty expertise, and administrative capabilities...
- The University of California, Los Angeles will receive $2.34 million under a Project Grant award from the Department of the Army Medical Command to target N-cadherin for inhibition of enzalutamide resistance and emergence of neuroendocrine prostate cancer. The grant is funded through the Military Medical Research and Development program (CFDA 12.420), which supports biomedical research to improve military and public health through innovative medical solutions for battlefield care and other...